Insider Transactions in Q4 2023 at Genelux Corp (GNLX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
32,535
-91.08%
|
$422,955
$13.56 P/Share
|
|
Dec 13
2023
|
James L Tyree |
SELL
Open market or private sale
|
Direct |
9,000
-47.27%
|
$117,000
$13.32 P/Share
|
|
Dec 13
2023
|
John Thomas |
SELL
Open market or private sale
|
Direct |
9,000
-0.96%
|
$117,000
$13.58 P/Share
|
|
Dec 07
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
36,800
-53.08%
|
$404,800
$11.85 P/Share
|
|
Nov 21
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
18,665
-21.21%
|
$186,650
$10.26 P/Share
|
|
Nov 20
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
14,594
-14.23%
|
$160,534
$11.26 P/Share
|
|
Nov 17
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
3,541
-3.34%
|
$46,033
$13.04 P/Share
|
|
Oct 25
2023
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
5,704
-0.41%
|
$108,376
$19.4 P/Share
|
|
Oct 24
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
5,200
-4.67%
|
$98,800
$19.11 P/Share
|
|
Oct 24
2023
|
Tony Yu VP, Clinical Trial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,200
+4.46%
|
$31,200
$6.0 P/Share
|
|
Oct 23
2023
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
49,987
-3.5%
|
$949,753
$19.97 P/Share
|
|
Oct 16
2023
|
John Thomas |
SELL
Open market or private sale
|
Direct |
3,333
-0.35%
|
$66,660
$20.9 P/Share
|
|
Oct 10
2023
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
5,200
-2.34%
|
$114,400
$22.43 P/Share
|
|
Oct 10
2023
|
Tony Yu VP, Clinical Trial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,200
+4.46%
|
$31,200
$6.0 P/Share
|
|
Oct 05
2023
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
14,251
-0.49%
|
$356,275
$25.18 P/Share
|
|
Oct 03
2023
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
75,690
-4.99%
|
$1,892,250
$25.49 P/Share
|